CoAching CD8+ T cells for tumor immunotherapy-the pantothenate way
- PMID: 34879235
- DOI: 10.1016/j.cmet.2021.11.009
CoAching CD8+ T cells for tumor immunotherapy-the pantothenate way
Abstract
The metabolic state of T cells strongly influences their effector function and anti-tumor efficacy. St. Paul et al. (2021) report that Tc22, a CD8+ T cell subset with potent anti-tumor activity, upregulates the pantothenate/coenzyme A (CoA) pathway and that treatment with CoA or pantothenate is sufficient to enhance tumor immunotherapy.
Copyright © 2021 Elsevier Inc. All rights reserved.
Comment on
-
Coenzyme A fuels T cell anti-tumor immunity.Cell Metab. 2021 Dec 7;33(12):2415-2427.e6. doi: 10.1016/j.cmet.2021.11.010. Cell Metab. 2021. PMID: 34879240
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
